(Allergan plc)

	AGN latest price $163.9067 (1.16%) ($161.4133 - $164.6791) on Thu. Dec. 21, 2017.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.79% (three month average)
RSI	47
Latest Price	$163.9067(1.16%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.4% a day on average for past five trading days.
Weekly Trend	AGN advances 0.6% a week on average for past two weeks.
Market Behavior	Value stock rally for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(51%)    XLV(50%)    XBI(47%)    ARKG(46%)    SPY(46%)
Factors Impacting AGN price	AGN will decline at least -0.895% in a week (0% probabilities).   VIXM(-31%)    TLT(-19%)    UUP(-17%)    GDXJ(-5%)    SHY(-4%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.895% (StdDev 1.79%)
Hourly BBV	0 ()
Intraday Trend	1.3%

1 - 5 Day Possible Target	$164.32(0.25%)
Resistance Level	$166.13
5 Day Moving Average	$165.34(-0.87%)
10 Day Moving Average	$165.98(-1.25%)
20 Day Moving Average	$166.13(-1.34%)
To recent high	-20.5%
To recent low	2%
Market Cap	$54.04b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed